Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: The significance of the intra-bone marrow injection

Journal of Autoimmunity

Volumn 30, Issue 3, 2008, Pages 136-144

  Sonoda, Yoshiaki ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

CD34 negative; Hematopoietic stem cell (HSC); Intra bone marrow injection (IBMI); SCID repopulating cell (SRC); SDF 1 CXCR4 axis

Indexed keywords

ALPHA4 INTEGRIN; BREAST CANCER RESISTANCE PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CYTOKINE RECEPTOR; FLT3 LIGAND; GEMTUZUMAB OZOGAMICIN; GLYCOPROTEIN GP 130; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR3 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 6 RECEPTOR; L SELECTIN; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; STEM CELL FACTOR; THY 1 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1;

BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL POPULATION; CELL RENEWAL; COMBINED IMMUNODEFICIENCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVIEW; UMBILICAL CORD BLOOD; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD34; BONE MARROW; CELL MOVEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; MICE; TRANSPLANTATION, HETEROLOGOUS;

EID: 39149098777     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.12.004     Document Type: Review

References (55)

1. Kondo M., Wagers A.J., Manz M.G., Prohaska S.S., Scherer D.C., Beihack G.F., et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 21 (2003) 759-806
2. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 81 (1993) 2844-2853
3. Mooree M.A.S. Clinical implications of positive and negative hematopoietic cell regulators. Blood 78 (1991) 1-19
4. null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100 (2002) 3175-3182
5. Larochelle A., Vormoor J., Hanenberg H., Wang J.C.Y., Bhatia M., Lapidot T., et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 2 (1996) 1329-1337
6. Guenechea G., Gan O.I., Dorrell C., and Dick J.E. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2 (2001) 75-82
7. + cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci U S A 99 (2002) 413-418
8. - cells: correlation between long-term culture-initiating cells and telomerase expression. Leukemia 12 (1998) 728-734
9. Tsuji T., Ogasawara H., Aoki Y., Tsurumaki Y., and Kodama H. Characterization of murine stromal cell clones established from bone marrow and spleen. Leukemia 10 (1996) 803-812
10. Krause D.S., Fackler M.J., Civin C.I., and May W.S. CD34: structure, biology, and clinical utility. Blood 87 (1996) 1-13
11. Bhatia M., Wang J.C.Y., Kapp U., Bonnet D., and Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 94 (1997) 5320-5325
12. Wang J.C.Y., Doedens M., and Dick J.E. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89 (1997) 3919-3924
13. - cells assured by intra-bone marrow injection. Blood 101 (2003) 2924-2931
14. - severe combined immunodeficiency repopulating cells that retain secondary reconstituting capacity. Int J Hematol 79 (2004) 328-333
15. Civin C., Trischmann T., Kadan N.S., Davis J., Noga S., Cohen K., et al. Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 14 (1996) 2224-2233
16. Osawa M., Hanada K., Hamada H., and Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic cell. Science 273 (1996) 242-245
17. van der Loo J.C., and Ploemacher R.E. Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 85 (1995) 2598-2606
18. Seita J., Ema H., Ooehara J., Yamazaki S., Tadokoro Y., Yamasaki A., et al. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci U S A 104 (2007) 2349-2354
19. Goodell M.A., Rosenzweig M., Kim H., Marks D.F., Demaria M., Paradis G., et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3 (1997) 1337-1345
20. van Hennik P.B., Koning A.E., and Ploemacher R.E. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood 94 (1999) 3055-3061
21. Verlinden S.E.F., van Es H.H.G., and van Bekkum D.W. Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice. Exp Hematol 26 (1998) 627-630
22. Kushida T., Inaba M., Hisha H., Ichioka N., Esumi T., Ogawa R., et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 97 (2001) 3292-3299
23. Bhatia M., Bonnet D., Murdoch B., Gan O.I., and Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 4 (1998) 1038-1045
24. + cells. Exp Hematol 26 (1998) 353-360
25. - hematopoietic cells. Blood 94 (1999) 4053-4059
26. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
27. - sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. Blood 100 (2002) 2778-2786
28. Yahata T., Ando K., Sato T., Miyatake H., Nakamura Y., Muguruma Y., et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101 (2003) 2905-2913
29. Papayannopoulou T., Priestley G.V., and Nakamoto B. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/kit ligand pathway. Blood 91 (1998) 2231-2239
30. + cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95 (2000) 3289-3296
31. Sato T., Laver J.H., and Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94 (1999) 2548-2554
32. Zanjani E.D., Almeida-Porada G., Livingston A.G., Zeng H., and Ogawa M. Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp Hematol 31 (2003) 406-412
33. Ito T., Tajima F., and Ogawa M. Developmental changes of CD34 expression by murine hematopoietic stem cells. Exp Hematol 28 (2000) 1269-1273
34. Tajima F., Sato T., Laver J.H., and Ogawa M. CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. Blood 96 (2000) 1989-1993
35. Dao M.A., Arevalo J., and Nolta J.A. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 101 (2003) 112-118
36. + highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein. Blood 84 (1994) 4099-4106
37. Lyman S.D., and Jacobsen S.E.W. c-kit ligand and flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91 (1998) 1101-1134
38. + stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15 (2001) 659-669
39. + lympho-myeloid stem cells lacking erythro-megakaryocytic potential: a revised road map for adult blood lineage commitment. Cell 121 (2005) 295-306
40. - severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells 25 (2007) 1348-1355
41. Abraham N., Li M., Vanella L., Peterson S., Ikehara S., and Asprinio D. Bone marrow stem cell transplant into intra-bone cavity prevent type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmun 30 (2008) 128-135
42. Boren E.J., Cheema G.S., Naguwa S.M., Ansari A.A., and Gershwin M.E. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 30 1-2 (2007) 90-98
43. Burt R., Craig R., Cohen B., Suffit R., and Barr W. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?. J Autoimmun 30 (2008) 116-120
44. Deane S., Meyers F., and Gershwin M. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun 30 (2008) 180-196
45. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 30 (2008) 105-107
46. Hara M., Murakami T., and Kobayashi E. In vivo bioimaging using photogenic rats: fate of injected bone marrow-derived mesenchymal stromal cells. J Autoimmun 30 (2008) 163-171
47. Ikehara S. Innovative BMT method for intractable diseases. Immunol Res 38 1-3 (2007) 251-260
48. Marmont A. Will hematopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmun 30 (2008) 145-150
49. Ozawa K., Sato K., Oh I., Ozaki K., Uchibori R., Obara Y., et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 30 (2008) 121-127
50. Ratajczak M.Z., Zuba-Surma E.K., Wysoczynski M., Wan W., Ratajczak J., Wojakowski W., et al. Hunt for pluripotent stem cell - regenerative medicine search for almighty cell. J Autoimmun 30 (2008) 151-162
51. Rezvani A., and Storb R. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 30 (2008) 172-179
52. Sonoda Y., Kimura T., Asada R., Kimura T., Morioka M., Sasaki Y., et al. Different proliferative potential and redistribution kinetics of human cord blood-derived CD34- SCID-repopulating cells (SRCs) in comparison with CD34+CD38+/- SRCs using intra-bone marrow injection. Blood 108 11 (2006) 470a
53. Sonoda Y., Yang Y.-C., Wong C.G., Clark S.C., and Ogawa M. Analysis in serum-free culture of the targets of recombinant human hematopoietic growth factors: Interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages. Proc Natl Acad Sci USA 85 (1988) 4360-4364
54. Sitnicka E., Buza-Vidas N., Larsson S., Nygren J.M., Liuba K., and Jacobsen S.E.W. Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 102 (2003) 881-886
55. Ebihara Y., Wada M., Ueda T., X-u M.-J., Manabe A., Tanaka R., et al. Reconstitution of human haematopoiesis in non-obese diabeteic/severe combined immunodefficient mice by clonal cells expanded from single CD34+CD38- cells expressing flk2/flt3. Br J Haematol 119 (2002) 525-534